H.ZhangX.TangX.PuH.et al (2020)
Those most at risk include vegans and vegetarians, people with digestive conditions such as Crohn's disease, coeliac disease or IBS, those taking long-term metformin or proton pump inhibitors, older adults whose ability to absorb B12 through the gut declines naturally with age, those with pernicious anaemia, and anyone with a history of chronic alcohol use
By stimulating the release of insulin and reducing the sensation of hunger, it assists individuals in achieving better blood sugar control while promoting significant weight loss
As word spread, and demand grew, Turnock said, wholesalers in the U.K
[4] Phase 3 trials (the TRIUMPH programme) are currently underway, with results anticipated in the coming years